Phenytoin administration in pregnancy - Effect of antioxidants on biochemical variables in pre- and postnatal development of rats

Biologia - Section Cellular and Molecular Biology

Volumn 60, Issue SUPPL. 17, 2005, Pages 51-55

  Navarová, Jana ^a   Ujházy, Eduard ^a   Dubovický, Michal ^a   Mach, Mojmír ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

GSH; Intrauterine hypoxia; Melatonin; NAGA; Phenytoin; Rat; Stobadine

Indexed keywords

EID: 33751331864     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. BALONOVÁ, T., ZELJENKOVÁ, D., ĎURIŠOVÁ , M., NOSÁL', R., JAKUBOVSKÝ, J., LÍŠKA, J. & ŠTOLC, S. 1991. Reproductive toxicity studies with cis-(-)-2,3,4,4a,5,9b- hexahydro-2,8-dimethyl-1H-pyrido-[4,3-b]indole dipalmitate in rats. Arzneimittel.-Forsch. 41:1-5.
2. BARRETT, A.J. & HEATH, M.F. 1977. Lysosomal enzymes, pp. 19-147. In: DINGLE, J.T. (ed.) Lysosomes: A Laboratory Handbook, 2nd ed., Elsevier, Amsterdam.
3. BROGAARD, B. & CLAUSEN, J. 1997. An in vitro system for evaluation of oxidative stress and the effects of antioxidants. ATLA 25: 279-287.
4. CHALUPA, I., BLAŠKO, M. & BENEŠ, L. 1993. In vitro micronucleus test of the cardioprotective agent stobadine. A genotoxicological study. Pharmazie 48: 206-207.
5. DANIELS, W.M.U., VAN RENSBURG, S.J., VAN ZYL, J.M., VAN DER WALT, B.J. & TALJAARD, J.J.F. 1996. Free radical scavenging effects of melatonin and serotonin: possible mechanism. NeuroReport 7: 1593-1596.
6. DANIELSSON, B.R., AZARBAYJANI, F., SKÖLD, A.C. & WEBSTER, W.S. 1997. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 56: 271-281.
7. DUBOVICKÝ, M., UJHÁZY, E., KOVAČOVSKÝ, P., NAVAROVÁ, J., JURÁNI, M. & ŠOLTÉS, L. 2004. Effect of melatonin on neurobehavioral dysfunctions induced by intrauterine hypoxia in rats. Central Eur. J. Public Health 12 (Suppl.): S23-S25.
8. EL-SOKKARY, G.H., KAMEL, E.S. & REITER, R.J. 2003. Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cell. Mol. Biol. Lett. 8: 461-470.
9. GAJDOŠÍKOVÁ, A., UJHÁZY, E., GAJDOŠÍK, A., CHALUPA, I., BLAŠKO, M., TOMÁŠ KOVÁ, A., LÍŠKA, J., DUBOVICKÝ, M. & BAUER, V. 1995. Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneimittel.-Forsch. 45: 531-536.
10. HORÁKOVÁ, L'. & ŠTOLC, S. 1998. Antioxidant and pharmacodynamic effects of pyridoindole stobadine: a review. Gen. Pharmacol. 30: 787-799.
11. KAGAN, V.E., TSUCHIYA, M., SERBINOVA, E., PACKER, L. & SIES, H. 1993. Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem. Pharmacol. 45: 393-400.
12. KEHRER, J.P. & LUND, L.G. 1994. Cellular reducing equivalents and oxidative stress. Free Rad. Biol. Med. 17: 65-75.
13. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.
14. MAČIČKOVÁ, T., PEČIVOVÁ, J., NOSÁL', R. & FÁBRYOVÁ, V. 2005. Is superoxide generation and β-D-glucuronidase release from stimulated human polymorphonuclear leukocytes influenced by stobadine? Biologia, Bratislava 60 (Suppl. 17): 137-140.
15. NAVAROVÁ, J., SEEMANNOVÁ, Z., UJHÁZY, E., SOTNÍKOVÁ, R., DUBOVICKÝ, M., MUCHOVÁ, S. & HORÁKOVÁ, K. 2000. Biochemical variables of oxidative cell and tissue damage induced by phenytoin. Biologia, Bratislava 55 (Suppl. 8): 81-85.
16. NAVAROVÁ, J., UJHÁZY, E., DUBOVICKÝ, M. & MACH, M. 2004. Effect of melatonin on biochemical variables induced by phenytoin in organs of mothers, foetuses and offsprings of rats. Central Eur. J. Public Health 12 (Suppl.): S67-S69.
17. NAVAROVÁ, J., UJHÁZY, E., LÍŠKA, J. & DUBOVICKÝ, M. 2003. Determination of selective biochemical variables in pregnant and lactating mice after stobadine administration. Methods Find. Exp. Clin. Pharmacol. 25: 717-721.
18. REITER, R.J., TAN, D.X., SAINZ, R.M., MAYO, J.C. & LOPEZ-BURILLO, S. 2002. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 54: 1299-1321.
19. SAINZ, R.M., MAYO, J.C., RODRIGUEZ, C., TAN, D.X., LOPEZ-BURILLO, S. & REITER, R.J. 2003. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell. Mol. Life Sci. 60:1407-1426.
20. SASTRE, J., ASENS, M., RODRIGO, F., PALLARDO, F.V., VENTO, M. & VINA, J. 1994. Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat. Life Sci. 54: 2055-2009.
21. SENER, G., KACMAZ, A., USER, Y., OZKAN, S., TIKLI, M. & YEGEN, B. C. 2003. Melatonin ameliorates oxidative organ damage induced by acute intra-abdominal compartment syndrome in rats. J. Pineal Res. 35:163-168.
22. SUN, J., CHEN, Y., LI, M. & GE, Z. 1998. Role of antioxidant enzyme on ionizing radiation resistance. Free Rad. Biol. Med. 24: 586-593.
23. ŠTEFEK, M. & TRNKOVÁ, Z. 1996. The pyridoindole antioxidant stobadine prevents alloxan-induced lipid peroxidation by inhibiting its propagation. Pharmacol. Toxicol. 78: 77-81.
24. ŠTOLC, S., VLKOLINSKÝ, V. & PAVLÁSEK, J. 1997. Neuroprotection by the pyridoindole stobadine: minireview. Brain Res. Bull. 42: 335-340.
25. TIETZE, F. 1969. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27: 502-522.
26. TURGUT, M., BASARAN, O., CEKMEN, M., KARATAS, F., KURT, A. & AYGUN, A. D. 2004. Oxidant and antioxidant levels in preterm newborns with idiopathic hyperbilirubinaemia. J. Paediatr. Child Health 40: 633-637.
27. UJHÁZY, E., DUBOVICKÝ, M., BALONOVÁ, T. & JANŠÁK, J. 1999. Teratological study of the antioxidant stobadine in rats. Gen. Physiol. Biophys. 18 (Focus Issue): 171-176.
28. UJHÁZY, E., MACH, M., DUBOVICKÝ, M., NAVAROVÁ, J., ŠOLTÉS, L., JURÁNEK, I., BRUCKNEROVÁ, I. & ZEMAN, M. 2004. Effect of melatonin and stobadine on maternal and embryofoetal toxicity in rats due to intrauterine hypoxia induced by phenytoin administration. Central Eur. J. Public Health 12 (Suppl.): S83-S86.
29. WELLS, P.G. & WINN, L.M. 1996. Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. Biol. 31: 1-40.
30. WELLS, P.G., KIM, P.M., LAPOSA, R.R., NICOL, C.J., PARMAN, T. & WINN, L.M. 1997. Oxidative damage in chemical teratogenesis. Mutat. Res. 396: 65-78.
31. WINN, L.M. & WELLS, P.G. 1997. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Free Rad. Biol. Med. 22: 607-621.
32. WINN, L.M. & WELLS, P.G. 1999. Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Rad. Biol. Med. 26: 266-274.
33. WONG, M. & WELLS, P.G. 1988. Effects of N-acetylcysteine on fetal development and phenytoin teratogenicity in mice. Teratogen. Carcinogen. Mutagen. 8: 65-79.
34. WONG, M. & WELLS, P.G. 1989. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea. J. Pharmacol. Exp. Ther. 250: 336-342.
35. WONG, M., HELSTON, L.M.J. & WELLS, P.G. 1989. Enhancement of murine phenytoin teratogenicity by gamma-glutamylcysteine synthetase inhibitor buthionine sulfoximine and the glutathione depletor diethylmaleate. Teratology 40: 127-141.